Finzati - Logo
GILD logo

Gilead Sciences, Inc.

GILD • Drug Manufacturers - General
$151.00
▼ -0.22 (-0.15%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$187.69B
Growth
27.9%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 28.9%Positive free cash flow · 7.6Consistent free cash flow · 5/5Reasonable earnings multiple · 17.94Healthy liquidity · 1.68
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:07 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$151.00
Change-0.15%
Shares Out1.24B
Market Cap$187.69B
Enterprise Value$184.51B
52W Range108.46 - 157.29
Beta0.34
P/E-57.93
P/S6.16
P/B15.98
P/FCF14.22
EV/Sales6.06

Investment DNA

How strong this company looks for long-term investors

76
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
81/100
Growth Potential
Revenue and expansion
31/100
Price Attractiveness
Cheap or expensive today
66/100
Why this score▼
Stable or improving margins · 28.9%Positive free cash flow · 7.6Consistent free cash flow · 5/5Reasonable earnings multiple · 17.94Healthy liquidity · 1.68Negative growth trend

Analyst view

Analyst sentiment and price target

GILD
Analyst sentiment
Based on 58 analyst votes · 2026-09-05
83/100
Bullish
Bullish
39
Hold
18
Bearish
1
Price Target
2026-08-07
Low
$123.00
Mean
$158.44
Median
$162.50
High
$180.00

Company Overview

IPO: 1/22/1992
Industry: Drug Manufacturers - General
P/B i: 15.98
Debt / Equity i: 1.09
Operating Margin: 39.74%
Net Margin: 28.90%
ROE i: -
ROIC: -

Financial Health

Score16 / 20
Debt / Equity: 1.09
Current Ratio: 1.68
Quick Ratio: 1.31
Status: Strong

Insider Transactions

Recent executive and insider activity

O'Day Daniel Patrick
Transaction: 08/03/2026
SELL
Change
-600
Price
$131.34
Filing
08/04/2026
Type
SELL
Mercier Johanna
Transaction: 07/15/2026
SELL
Change
-3,000
Price
$129.92
Filing
07/16/2026
Type
SELL
Dickinson Andrew D
Transaction: 07/15/2026
SELL
Change
-3,000
Price
$129.93
Filing
07/16/2026
Type
SELL